Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
Alessandro Mantovani, Christopher D Byrne, Giovanni Targher
Topics & Concepts
MedicineFatty liverGlucagon-like peptide 1 receptorEmpagliflozinLiraglutideReceptorInternal medicinePharmacologyClinical trialNonalcoholic fatty liver diseaseSteatohepatitisEndocrinologyType 2 diabetesPeroxisomePeroxisome proliferator-activated receptor alphaDiseasePeroxisome proliferator-activated receptorSteatosisBioinformaticsLiver diseaseMineralocorticoid receptorLiver enzymeMelanocortin 4 receptorLiver Disease Diagnosis and TreatmentDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins